Pradžia › Priepuoliai › New Jersey
Priepuoliai klinikiniai tyrimai New Jersey
8 tyrimai dėl Priepuoliai ieško dalyvių vietose New Jersey.
Miestai New Jersey
Oficialus tyrimo tekstas (anglų kalba)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Tekton Research, Marlboro
Renkami dalyviai3 fazė
Amžius nuo 2 iki 55 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Hackensack Meridian Neuroscience Institute at JFK University Medical Center, Edison
- Saint Peter's University Hospital, New Brunswick
Renkami dalyviai1 fazė
Amžius nuo 12 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Northeast Regional Epilepsy Group - Hackensack, Hackensack
- Hackensack Meridian Health Jersey Shore University Medical Center, Neptune City
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Northeast Regional Epilepsy Group, Hackensack
- Institute of Neurology and Neurosurgery at St. Barnabas, Livingston
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07563881A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Neurology Center for Epilepsy and Seizures, Marlboro
Renkami dalyviai3 fazė
Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT04462770A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Northeast Regional Epilepsy Group, Hackensack
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-14 · NCT05716100Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Northeast Regional Epilepsy Group, Hackensack
Renkami dalyviai3 fazė
Amžius nuo 4 iki 55 · Visoms lytims · Atnaujinta 2025-07-24 · NCT05219617An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Hackensack
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2025-04-03 · NCT06908356Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.